Group 1 - Qiantang (New) District has launched a new round of industrial fund matrix, including Qiantang and Da Industrial Fund, operating under the "mother fund + sub-fund" model [1] - Over the past 8 years, the total cooperation scale of Qiantang Industrial Fund has exceeded 45 billion yuan, investing in 266 local enterprises, including 6 listed companies and 71 (quasi) unicorns [1] - The fund has supported the development of high-tech products, such as the successful overseas launch of paclitaxel injection by Hangzhou Haichang Biotechnology Co., Ltd. in nearly 40 countries [1] Group 2 - The new fund matrix includes 7 non-directional funds focused on Qiantang's advantageous industries and 6 directional funds aimed at attracting major projects, covering the entire lifecycle of key industries [2] - The management sub-fund has actively assisted Tianjing Biotechnology in asset restructuring, helping the company secure over 500 million yuan in C1 round financing [2] - Qiantang Industrial Fund will continue to focus on hard technology, maintain long cycles, and enhance error tolerance to support rapid development of local enterprises [2]